Related Experiment Video
Updated: May 30, 2026

Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
Published on: March 14, 2019
Advances in the diagnosis and management of pediatric osteomyelitis
Isaac Thomsen1, C Buddy Creech
1Department of Pediatrics, Division of Pediatric Infectious Diseases, Vanderbilt University School of Medicine and the Monroe Carell, Jr. Children's Hospital at Vanderbilt, Nashville, TN, USA, isaac.thomsen@vanderbilt.edu.
Insights
Acute hematogenous osteomyelitis in children requires updated diagnostic and therapeutic strategies. Recent advances include recognizing new pathogens and optimizing antimicrobial treatments for better outcomes.
Area of Science:
- Pediatrics
- Infectious Diseases
- Orthopedic Surgery
Background:
- Acute hematogenous osteomyelitis is a frequent pediatric infection with evolving etiological factors.
- Limited data exist for optimizing diagnosis and therapy in children.
- Recent shifts in causative organisms include increased recognition of Kingella kingae and community-associated Methicillin-resistant Staphylococcus aureus (CA-MRSA).
Purpose of the Study:
- To review recent investigations into the optimal diagnosis and management of acute hematogenous osteomyelitis in children.
- To highlight changes in etiology and emerging treatment strategies.
- To provide guidance on current diagnostic and therapeutic approaches.
Main Methods:
- Review of recent literature on pediatric osteomyelitis.
- Analysis of diagnostic advancements, including MRI and inflammatory markers.
- Evaluation of current and emerging treatment strategies, including oral antimicrobial therapy and shortened treatment durations.
Main Results:
- Evolving understanding of osteomyelitis etiology with increased prevalence of K. kingae and CA-MRSA.
- Need for optimized diagnostic tools like MRI and serum markers.
- Emerging treatment paradigms favor early oral step-down therapy and potentially shorter treatment courses.
Conclusions:
- Optimizing diagnostic strategies and adapting to changing pathogens are crucial for managing pediatric osteomyelitis.
- New therapeutic options are emerging, promising improved management of childhood bacterial bone infections.
- This review synthesizes current evidence to guide clinical practice in pediatric osteomyelitis.
Abstract:
Acute hematogenous osteomyelitis is a common disease that affects previously healthy children of all age groups. Despite its importance, there are limited data in the current literature to guide many aspects of the diagnosis and therapy of this infection. Over the last decade, our understanding of the etiology of this infection has changed, with increased recognition of Kingella kingae and the dramatic increase in community-associated Methicillin-resistant Staphylococcus aureus (CA-MRSA) infections. There is a need for the optimization of diagnostic strategies, such as MRI and serum inflammatory markers. Several recent studies have examined treatment strategies, including a rapid transition to oral antimicrobial therapy and a shortened overall course of therapy. Many new therapeutic options are on the horizon that will likely impact the management of this and other childhood bacterial infections. This review summarizes recent investigations into the optimal diagnosis and management of acute hematogenous osteomyelitis in children.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis III: Medical Management
Tonsillitis II: Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: